Noteboom J - Search Results

1

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.

Sokoll LJ, Ellis W, Lange P, Noteboom J, Elliott DJ, Deras IL, Blase A, Koo S, Sarno M, Rittenhouse H, Groskopf J, Vessella RL. Sokoll LJ, et al. Among authors: noteboom j. Clin Chim Acta. 2008 Mar;389(1-2):1-6. doi: 10.1016/j.cca.2007.11.003. Epub 2007 Nov 17. Clin Chim Acta. 2008. PMID: 18061575

2

Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.

Vessella RL, Noteboom J, Lange PH. Vessella RL, et al. Among authors: noteboom j. Clin Chem. 1992 Oct;38(10):2044-54. Clin Chem. 1992. PMID: 1382897

3

Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay.

Ellis WJ, Vessella RL, Noteboom JL, Lange PH, Wolfert RL, Rittenhouse HG. Ellis WJ, et al. Among authors: noteboom jl. Urology. 1997 Oct;50(4):573-9. doi: 10.1016/S0090-4295(97)00251-3. Urology. 1997. PMID: 9338734 Clinical Trial.

4

Serum percent free prostate-specific antigen in metastatic prostate cancer.

Lin DW, Noteboom JL, Blumenstein BA, Ellis WJ, Lange PH, Vessella RL. Lin DW, et al. Among authors: noteboom jl. Urology. 1998 Sep;52(3):366-71. doi: 10.1016/s0090-4295(98)00240-4. Urology. 1998. PMID: 9730445

5

Urinary prostate specific antigen levels after radical prostatectomy.

Takayama TK, Vessella RL, Brawer MK, True LD, Noteboom J, Lange PH. Takayama TK, et al. Among authors: noteboom j. J Urol. 1994 Jan;151(1):82-7. doi: 10.1016/s0022-5347(17)34877-2. J Urol. 1994. PMID: 7504747

6

The percentage of free prostate-specific antigen does not predict extracapsular disease in patients with clinically localized prostate cancer before radical prostatectomy.

Melchior SW, Noteboom J, Gillitzer R, Lange PH, Blumenstein BA, Vessella RL. Melchior SW, et al. Among authors: noteboom j. BJU Int. 2001 Aug;88(3):221-5. doi: 10.1046/j.1464-410x.2001.02236.x. BJU Int. 2001. PMID: 11488733

7

The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay.

Takayama TK, Vessella RL, Brawer MK, Noteboom J, Lange PH. Takayama TK, et al. Among authors: noteboom j. J Urol. 1993 Aug;150(2 Pt 1):374-8. doi: 10.1016/s0022-5347(17)35486-1. J Urol. 1993. PMID: 7686983

8

Circulating microRNAs as stable blood-based markers for cancer detection.

Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Mitchell PS, et al. Among authors: noteboom j. Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8. doi: 10.1073/pnas.0804549105. Epub 2008 Jul 28. Proc Natl Acad Sci U S A. 2008. PMID: 18663219 Free PMC article.

9

Elevation of cytokine levels in cachectic patients with prostate carcinoma.

Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D Jr, Corey E. Pfitzenmaier J, et al. Among authors: noteboom jl. Cancer. 2003 Mar 1;97(5):1211-6. doi: 10.1002/cncr.11178. Cancer. 2003. PMID: 12599227 Free article.

10

Bayer Immuno 1 PSA Assay: an automated, ultrasensitive method to quantitate total PSA in serum.

Morris DL, Dillon PW, Very DL, Ng P, Kish L, Goldblatt JL, Bruzek DJ, Chan DW, Ahmed MS, Witek D, Fritsche HA, Smith C, Schwartz D, Schwartz MK, Noteboom JL, Vessella RL, Yeung KK, Allard WJ. Morris DL, et al. Among authors: noteboom jl. J Clin Lab Anal. 1998;12(1):65-74. doi: 10.1002/(SICI)1098-2825(1998)12:1<65::AID-JCLA11>3.0.CO;2-M. J Clin Lab Anal. 1998. PMID: 9484672 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters